SEC Filing Summary: BioSig Technologies, Inc. (BSGM)
Business Context and Reporting Period
This Form 8-K Current Report was filed by BioSig Technologies, Inc. on November 10, 2021. The registrant is incorporated in Delaware and trades on the NASDAQ Capital Market under the symbol BSGM. The report serves as a Regulation FD disclosure regarding a specific business development.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This document is a current report focused on a qualitative business update rather than a financial statement.
Material Changes
The primary material event disclosed is the expansion of the Company's installation base in Texas. No quantitative comparison to prior periods is provided in this filing.
Guidance, Outlook, and Risks
Management commentary is limited to the announcement of the Texas expansion. The filing explicitly states that the Company undertakes no obligation to update, supplement, or amend the attached press release materials. The document includes standard disclaimers that the information is not deemed "filed" for liability purposes under Section 18 of the Exchange Act and is not intended to constitute a determination of materiality under Regulation FD.
Investor Verification Checklist
- Verify the details of the Texas installation base expansion in the attached press release (Exhibit 99.1).
- Confirm the trading status of BSGM on the NASDAQ Capital Market.
- Note that this filing does not contain audited financial data or forward-looking guidance.
- Review the signature of Kenneth L. Londoner, Executive Chairman, as the authorized signatory.